Parabilis Medicines, Inc. (NASDAQ:PBLS) Financings

Parabilis Medicines, Inc.

Financings

RaiseDate
Public offering of common stock
Closed: US$770.5M raised · US$20 a share · Leerink Partners +4
Dealers: Leerink Partners (co-lead), BofA Securities (co-lead), Evercore ISI (co-lead), Guggenheim Securities (co-lead), LifeSci Capital
Jun 11, 2026
Private placement of common stock
Closed: US$75M raised · US$18 a share
Buyers: Regeneron Pharmaceuticals, Inc. (4,166,666 shares of common stock at $18.00 per share)
Jun 11, 2026

Read by 6ix AI from the company's releases